Chevy Chase Trust’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-143,940
Closed -$2.5M 631
2023
Q3
$2.5M Sell
143,940
-3,084
-2% -$64.3K 0.01% 533
2023
Q2
$3.06M Sell
147,024
-1,068
-0.7% -$23.2K 0.01% 526
2023
Q1
$3.48M Buy
148,092
+2,041
+1% +$54.8K 0.01% 520
2022
Q4
$4.08M Sell
146,051
-9,798
-6% -$251K 0.02% 522
2022
Q3
$3.65M Buy
155,849
+1,213
+0.8% +$36.6K 0.02% 519
2022
Q2
$5.22M Buy
154,636
+572
+0.4% +$20K 0.02% 489
2022
Q1
$5.38M Buy
154,064
+243
+0.2% +$8.31K 0.02% 504
2021
Q4
$4.68M Sell
153,821
-3,669
-2% -$120K 0.02% 516
2021
Q3
$5.17M Sell
157,490
-9,767
-6% -$313K 0.02% 505
2021
Q2
$5.06M Buy
+167,257
New +$5.51M 0.02% 514

Other funds holding OGN

Chevy Chase Trust's OGN Position: Q4 2023 in Review

Chevy Chase Trust sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 143,940 shares — an estimated $2.5M sold.

Chevy Chase Trust first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $5.38M in Q1 2022. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Chevy Chase Trust reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Chevy Chase Trust sold 143,940 Organon & Co shares in Q4 2023, an estimated $2.5M.
  • Chevy Chase Trust first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
  • Chevy Chase Trust's Organon & Co position peaked at $5.38M in Q1 2022.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Chevy Chase Trust's 13F filing for Q4 2023, filed 24 Jan 2024.